You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 6, June 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Annual Rate of Psoralen and Ultraviolet-A Treatment of Psoriasis After Initial Clearing

John W. Melski, MD; Robert S. Stern, MD

Arch Dermatol. 1982;118(6):404-408.


Abstract

• After the initial clearing phase, the mean rate of treatment with psoralen and ultraviolet-A (PUVA) radiation among 839 patients with psoriasis was 29.6 treatments a year during an average of 18.6 months. The initial percentage of skin surface involved with psoriasis was the single best indicator of the rate of treatment needed. The previous use of other therapies and the presence of certain environmental factors (eg, isomorphic response to injury, leisure time spent mostly indoors, and cold weather having no effect on psoriasis) were associated with additive increases in rate. Patients with none of these factors had an average of 5.4 treatments a year less than was predicted by the extent of skin involvement alone, whereas patients with previous use of four or more therapies and three environmental factors had 10.4 more treatments a year.

(Arch Dermatol 1982; 118:404-408)



Author Affiliations

From the Departments of Dermatology (Dr Stern) and Medicine (Dr Melski), the Laboratory of Computer Medicine (Dr Melski), the Charles A. Dana Research Institute and Harvard-Thorndike Laboratory (Drs Stern and Melski), Beth Israel Hospital and Harvard Medical School; and the Center for the Analysis of Health Practices, Harvard School of Public Health (Dr Stern), Boston.


Footnotes

Accepted for publication Jan 20, 1982.

Reprint requests to Laboratory of Computer Medicine, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02115 (Dr Melski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Koebner (Isomorphic) Response in Psoriasis: Associations With Early Age at Onset and Multiple Previous Therapies
Melski et al.
Arch Dermatol 1983;119:655-659.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.